How Medacta Continues to Drive Above-Market Growth

orthopedic market growth

Medacta is expanding significantly faster than its competitors, especially in joint replacement. The Swiss-based company achieved sales of $551 million in 2023 and 17% growth over 2022, substantially outpacing the orthopedic market. Nearly 40% of those sales came from the company’s knee replacement business. Medacta’s personalized...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us